In previous analysis focused on Taiwan region [32], the composing proportion of comorbidities and medications in baseline was different from our study; and the study only included BNP as the heart failure biomarker which is known to be affected by neprilysin inhibitor [33, 34]. Here, NPPB is linked to heart failure.